Intervention
Total-Body Irradiation
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
2 shownCommon conditions
Acute Lymphoblastic Leukemia2Acute Myeloid Leukemia2Chronic Myelogenous Leukemia, BCR-ABL1 Positive2Myelodysplastic Syndrome2Myelodysplastic Syndrome With Excess Blasts2Non-Hodgkin Lymphoma2Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Acute Biphenotypic Leukemia1Acute Erythroid Leukemia1Acute Leukemia1Acute Lymphoblastic Leukemia in Remission1Acute Megakaryoblastic Leukemia1Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome1Chemotherapy-Related Leukemia1Chronic Lymphocytic Leukemia1Chronic Myelomonocytic Leukemia1Hematopoietic and Lymphoid Cell Neoplasm1HIV Infection1Hodgkin Lymphoma1Langerhans Cell Histiocytosis1Minimal Residual Disease1Recurrent Hodgkin Lymphoma1Refractory Acute Lymphoblastic Leukemia1Refractory Anemia1Refractory Myelodysplastic Syndrome1
Leading sponsors
Trial status mix
COMPLETED1
TERMINATED1
Phase mix
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.